Triple

T1613302
Position Surface form Disambiguated ID Type / Status
Subject Public Health Service Act E34657 entity
Predicate relatedTo P37 FINISHED
Object Federal Food, Drug, and Cosmetic Act E31160 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Federal Food, Drug, and Cosmetic Act | Statement: [Public Health Service Act, relatedTo, Federal Food, Drug, and Cosmetic Act]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Federal Food, Drug, and Cosmetic Act
Context triple: [Public Health Service Act, relatedTo, Federal Food, Drug, and Cosmetic Act]
  • A. Federal Food, Drug, and Cosmetic Act chosen
    The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
  • B. Kefauver–Harris Drug Amendments of 1962
    The Kefauver–Harris Drug Amendments of 1962 are U.S. federal regulations that strengthened drug safety and efficacy requirements, mandating proof of effectiveness and stricter oversight of pharmaceutical marketing and manufacturing.
  • C. Food and Drug Administration Modernization Act of 1997
    The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
  • D. Food and Drug Administration Amendments Act of 2007
    The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
  • E. Pure Food and Drug Act of 1906
    The Pure Food and Drug Act of 1906 was a landmark U.S. federal law that laid the foundation for modern consumer protection by prohibiting the manufacture and sale of adulterated or misbranded foods and drugs and leading to the creation of federal regulatory oversight.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a885ffc5ec819091afa325d5f9611c completed March 4, 2026, 7:20 p.m.
NER Named-entity recognition batch_69a9098e245c8190b0169b648434aa49 completed March 5, 2026, 4:41 a.m.
NED1 Entity disambiguation (via context triple) batch_69ad51ca2bc48190abb83f4d84782334 completed March 8, 2026, 10:39 a.m.
Created at: March 4, 2026, 7:28 p.m.